Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Plos One|August 29, 2015
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in ObesityManikandan Subramanian, Lale Ozcan, Devram Sampat Ghorpade, et al.Proceedings of the National Academy of Sciences of the United States of America|September 24, 2014
Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathwayGabrielle Fredman, Lale Ozcan, Stefano Spolitu, et al.Journal of Gynecology Obstetrics and Human Reproduction|September 12, 2021
Double daily doses of cetrorelix may raise follicular phase progesterone more compared to single doses in poor ovarian response patientsMustafa Ozturk, Ulas Fidan, Temel Ceyhan, et al.Cell Metabolism|November 26, 2013
Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signalingLale Ozcan, Jane Cristina de Souza, Alp Avi Harari, et al.Molecular Cell|March 18, 2008
Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosisUmut Ozcan, Lale Ozcan, Erkan Yilmaz, et al.Circulation Research|December 25, 2018
Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein CholesterolStefano Spolitu, Haruka Okamoto, Wen Dai, et al.Plos One|May 13, 2021
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosisLale Ozcan, Canan Kasikara, Arif Yurdagul, et al.Journal of Lipid Research|February 3, 2024
Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9Yating Wang, Brea Tinsley, Stefano Spolitu, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Geranylgeranyl Isoprenoids and Hepatic Rap1a Regulate Basal and Statin-Induced Expression of PCSK9Yating Wang, Brea Tinsley, Stefano Spolitu, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Insulin sensitization by hepatic FoxO deletion is insufficient to lower atherosclerosis in miceMaría Concepción Izquierdo, Michael Harris, Niroshan Shanmugarajah, et al.Pageof 4